Presented in Collaboration with:

This activity is supported by Bristol Myers Squibb and made possible through an independent grant from Merck & Co., Inc. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.

Topics Covered

Overview of Lobular Breast Cancer
Understanding Your Pathology Report for Lobular Carcinoma in Situ (LCIS)
Understanding Your Pathology Report for Invasive Lobular Carcinoma
The Role of Genetic Testing & Counseling
Current Standard of Care, including Surgery
New Treatment Approaches
Updates on Clinical Trials
How Clinical Research Increases Your Treatment Options
Biomarkers, Diagnostic Testing and Technologies: Why They Are Important in Informing Treatment Decisions for Invasive Lobular Carcinoma
Preventing and Managing Treatment Side Effects, Symptoms, Discomfort and Pain
Communicating with Your Health Care Team about Quality-of-Life Concerns
Guidelines for Preparing for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
Questions for Our Panel of Experts

Facilitators

Facilitator

Rebecca Shatsky, MD

Medical Oncologist, Associate Professor of Medicine, UC San Diego Health

Facilitator

Wade Smith, MD

Breast Cancer Specialist, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Newport Beach, California

Facilitator

Kamel Abou Hussein, MD

Assistant Professor of Medicine, Cooper Medical School of Rowan University, Adjunct Assistant Professor, Department of Breast Medical Oncology, MD Anderson Cancer Center, Co-Director of the Janet Knowles Breast Cancer Program, Director of Breast Cancer Clinical Trials, MD Anderson Cancer Center at Cooper

Facilitator

Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R

Senior Director of Education and Training, CancerCare

Ways to Give

Get Involved

Lobular Breast Cancer: Treatment Progress

Presented in Collaboration with:

Topics Covered

Facilitators